Clinical Trial Update: Oral Lactoferrin Supplementation for Prevention of Sepsis in Preterm Neonate [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating oral lactoferrin supplementation to prevent sepsis in preterm neonates; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Sepsis

Drugs mentioned

• Lactoferrin (lactoferrin)

Snippet

Sponsor: Mooselmokadem | Conditions: Neonatal Sepsis | EARLY_Phase 1 | Status: UNKNOWN